Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction: a Randomized Control Trial
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The purpose of this study is to determine if intraosseous (IO) morphine decreases pain and post-operative opioid use in patients undergoing anterior cruciate ligament (ACL) reconstruction.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: f
View:
• Patients of the IRB approved surgeon(s) undergoing ACL reconstruction with bone-to-bone (BTB) autograft
• Patients aged between 18-40 years old at the time of surgery
Locations
United States
Texas
Houston Methodist Research Institute
RECRUITING
Houston
Contact Information
Primary
Haley Goble, MHA
hmgoble@houstonmethodist.org
713-441-3930
Time Frame
Start Date: 2024-08-19
Estimated Completion Date: 2029-07-31
Participants
Target number of participants: 84
Treatments
Experimental: Intraosseous Injection of Morphine
The intervention group will receive an intraosseous (IO) injection of 10mg of morphine mixed with up to 100mg of saline into the tibial tubercle during a standard ACL reconstruction.
No_intervention: Standard of Care Morphine Administration
The control group will receive the standard of care treatment, which is no IO injection during a standard ACL reconstruction.
Related Therapeutic Areas
Sponsors
Leads: The Methodist Hospital Research Institute